Marketing, Business Development, and Sales Acceleration, Without Fixed Overhead.
In today’s biotech and life science markets, capital efficiency is necessary.
Funding cycles are longer, sales cycles are slower, and investors demand traction before term sheets. Yet the need for commercialization expertise has never been greater.
Enter the fractional go-to-market team: a new way to build high-performance marketing, business development, and sales engines without the fixed overhead of full-time headcount.
What Is a Fractional Go-to-Market Team?
A fractional GTM team delivers the same strategic and tactical horsepower as a traditional in-house commercial organization, but on demand.
It blends senior-level strategy (the “why and where”) with operational execution (the “how and when”) across three disciplines:
-
Marketing Execution:
-
Brand strategy, messaging, and content creation
-
Omnichannel campaigns (email, LinkedIn, paid, events)
-
CRM and marketing automation optimization (e.g., HubSpot, Salesforce)
-
-
Business Development:
-
Account-based prospecting, lead scoring, and MQL generation
-
Channel/distributor recruitment and management
-
Partnership and OEM engagement
-
-
Sales Acceleration:
-
Pipeline design and forecasting
-
Inside/outside sales enablement
-
Playbooks, KPIs, and weekly execution rhythms
-
Instead of hiring three senior leaders, VP of Marketing, VP of BD, and VP of Sales, plus their teams, fractional resources allow you to plug in proven experts for the exact bandwidth and outcomes you need.
Why the Model Works
1. Speed Without Overhead
Traditional hiring takes months. Fractional teams deploy in weeks, often integrating directly into existing CRM, content, and meeting rhythms to drive immediate results.
2. Integrated, Cross-Functional Execution
Fractional marketing, BD, and sales work as one system. Messaging, outreach, and pipeline management operate under a unified strategy, no silos or hand-offs lost in translation.
3. Experience That Scales
Our fractional executives have already built and run teams at many Biotech companies. Their playbooks and metrics are transferable, compressing years of learning into a few months of acceleration.
4. Data-Driven and Measurable
Every engagement is structured around quantifiable KPIs: number of MQLs, discovery calls, proposals, conversions, and closed revenue. The model thrives on visibility and accountability.
5. Capital Efficiency
Fractional resources convert fixed costs (salaries, benefits, recruiting fees) into variable investments tied to outcomes. You gain senior leadership and scalable execution, without long-term financial commitments and risks.
The PSG Life Sciences Approach
At PSG Life Sciences, we’ve refined the fractional commercialization model specifically for life science organizations, from early-stage biotech to global CROs and tool providers.
-
Strategic leadership (Fractional Chief Commercial Officers, CMOs, or VPs of BD)
-
Executional teams (marketing automation, SDRs, content, lead gen)
-
Analytics and CRM optimization (HubSpot, Salesforce, PubGrade, LinkedIn Sales Navigator)
Each engagement begins with an Assessment, evaluating your people, process, technology, and execution rhythm. We then build a 90-day acceleration plan that prioritizes measurable outcomes: more qualified leads, faster deal flow, and stronger brand visibility.
The Takeaway
The commercialization challenges facing life science companies today, longer sales cycles, leaner budgets, and investor scrutiny, demand a smarter operating model.
Fractional go-to-market teams offer the speed, experience, and scalability to compete, turning commercial execution into a measurable, repeatable growth engine.
At PSG Life Sciences, we help you build it, one cycle, one customer, one success story at a time.
Interested in learning more?
Contact steve@psglifesciences.com to explore how a fractional GTM team can accelerate your growth without adding fixed overhead.